特雷维治疗 TRVI
$14.33 +$1.52 (+11.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.90 +3.98%
开盘$13.04
昨收$12.81
当日区间$13.00 – $14.36
成交量2.55M
市值$2.04B
市盈率（TTM）–
股息率–
TRVI 相关新闻
匹配 Trevi Therapeutics 或代码 TRVI 的头条新闻，按最新排序。
- Trevi Therapeutics (TRVI) Receives a Buy From H.C. Wainwright
- H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $24
- A Quick Look at Today's Ratings for Trevi Therapeutics(TRVI.US), With a Forecast Between $23 to $40
- Trevi Therapeutics (TRVI) Receives a New Rating From B. Riley Securities
- Oppenheimer Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $25 正面
- Stifel Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $30
- Morgan Stanley Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $23 正面
- JonesTrading Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $28 正面
- Morgan Stanley Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $23
- BMO Capital Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $36
- BMO Capital Initiates Trevi Therapeutics(TRVI.US) With Buy Rating, Announces Target Price $36
- H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $24 正面
- Needham Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $23
- Clear Street Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $29 正面
- H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $21
暂无评论——快来第一个聊聊 TRVI。
登录后参与讨论。